Roche, UZH and USZ have signed a research agreement, announced the Basel-based pharmaceutical company in a statement. Together, the three partner organizations aim to investigate how health data collected during routine healthcare can be integrated into clinical practice. The goal is to "create a health data ecosystem" in which this so-called Real World Data (RWD) “can be trustfully, transparently and lawfully exchanged”, writes Roche.
The project will initially focus on data from oncology patients. A corresponding project within a public-private partnership is being developed and co-financed by the three project participants. It is called Precision Oncology Program and has already been approved by the ethics commission of the Canton of Zurich, according to the statement.
“Cancer is a very heterogeneous disease,” Prof. Dr. Andreas Wicki, Director of the Clinical Program of the Comprehensive Cancer Center Zürich is quoted as saying in the statement. “The structured and broad-based recording of RWD, as in the Precision Oncology Programme, may help to treat patients better in the long term because we have more information about very specific clinical situations.”
Dr. Katharina Gasser, General Manager of Roche Pharma Switzerland, is confident that the project “will generate meaningful insights not only to the project partners and patients involved, but to the Swiss healthcare system overall”. ce/hs
Related news
Contact us
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?
info@greaterzuricharea.com